Literature DB >> 19476346

Glycosylated SV2 and gangliosides as dual receptors for botulinum neurotoxin serotype F.

Zhuji Fu1, Chen Chen, Joseph T Barbieri, Jung-Ja P Kim, Michael R Baldwin.   

Abstract

Botulinum neurotoxin causes rapid flaccid paralysis through the inhibition of acetylcholine release at the neuromuscular junction. The seven BoNT serotypes (A-G) have been proposed to bind motor neurons via ganglioside-protein dual receptors. To date, the structure-function properties of BoNT/F host receptor interactions have not been resolved. Here, we report the crystal structures of the receptor binding domains (HCR) of BoNT/A and BoNT/F and the characterization of the dual receptors for BoNT/F. The overall polypeptide fold of HCR/A is essentially identical to the receptor binding domain of the BoNT/A holotoxin, and the structure of HCR/F is very similar to that of HCR/A, except for two regions implicated in neuronal binding. Solid phase array analysis identified two HCR/F binding glycans: ganglioside GD1a and oligosaccharides containing an N-acetyllactosamine core. Using affinity chromatography, HCR/F bound native synaptic vesicle glycoproteins as part of a protein complex. Deglycosylation of glycoproteins using alpha(1-3,4)-fucosidase, endo-beta-galactosidase, and PNGase F disrupted the interaction with HCR/F, while the binding of HCR/B to its cognate receptor, synaptotagmin I, was unaffected. These data indicate that the HCR/F binds synaptic vesicle glycoproteins through the keratan sulfate moiety of SV2. The interaction of HCR/F with gangliosides was also investigated. HCR/F bound specifically to gangliosides that contain alpha2,3-linked sialic acid on the terminal galactose of a neutral saccharide core (binding order GT1b = GD1a >> GM3; no binding to GD1b and GM1a). Mutations within the putative ganglioside binding pocket of HCR/F decreased binding to gangliosides, synaptic vesicle protein complexes, and primary rat hippocampal neurons. Thus, BoNT/F neuronal discrimination involves the recognition of ganglioside and protein (glycosylated SV2) carbohydrate moieties, providing a structural basis for the high affinity and specificity of BoNT/F for neurons.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19476346      PMCID: PMC2709598          DOI: 10.1021/bi9002138

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  57 in total

1.  The crystal structure of tetanus toxin Hc fragment complexed with a synthetic GT1b analogue suggests cross-linking between ganglioside receptors and the toxin.

Authors:  C Fotinou; P Emsley; I Black; H Ando; H Ishida; M Kiso; K A Sinha; N F Fairweather; N W Isaacs
Journal:  J Biol Chem       Date:  2001-06-19       Impact factor: 5.157

Review 2.  Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins.

Authors:  E A Johnson
Journal:  Annu Rev Microbiol       Date:  1999       Impact factor: 15.500

Review 3.  Botulinum toxin as a biological weapon: medical and public health management.

Authors:  S S Arnon; R Schechter; T V Inglesby; D A Henderson; J G Bartlett; M S Ascher; E Eitzen; A D Fine; J Hauer; M Layton; S Lillibridge; M T Osterholm; T O'Toole; G Parker; T M Perl; P K Russell; D L Swerdlow; K Tonat
Journal:  JAMA       Date:  2001-02-28       Impact factor: 56.272

4.  Botulism due to Clostridium baratii type F toxin.

Authors:  Sydney M Harvey; Joan Sturgeon; David E Dassey
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

Review 5.  Clostridium botulinum and its neurotoxins: a metabolic and cellular perspective.

Authors:  E A Johnson; M Bradshaw
Journal:  Toxicon       Date:  2001-11       Impact factor: 3.033

6.  Two carbohydrate binding sites in the H(CC)-domain of tetanus neurotoxin are required for toxicity.

Authors:  Andreas Rummel; Steffen Bade; Jürgen Alves; Hans Bigalke; Thomas Binz
Journal:  J Mol Biol       Date:  2003-02-21       Impact factor: 5.469

7.  Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice.

Authors:  M Kitamura; K Takamiya; S Aizawa; K Furukawa; K Furukawa
Journal:  Biochim Biophys Acta       Date:  1999-10-18

8.  Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I.

Authors:  Brian C Yowler; Richard D Kensinger; Cara-Lynne Schengrund
Journal:  J Biol Chem       Date:  2002-06-27       Impact factor: 5.157

9.  Functional characterisation of tetanus and botulinum neurotoxins binding domains.

Authors:  G Lalli; J Herreros; S L Osborne; C Montecucco; O Rossetto; G Schiavo
Journal:  J Cell Sci       Date:  1999-08       Impact factor: 5.285

10.  Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin.

Authors:  G Schiavo; F Benfenati; B Poulain; O Rossetto; P Polverino de Laureto; B R DasGupta; C Montecucco
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

View more
  68 in total

1.  Unique biological activity of botulinum D/C mosaic neurotoxin in murine species.

Authors:  Keiji Nakamura; Tomoko Kohda; Yuto Shibata; Kentaro Tsukamoto; Hideyuki Arimitsu; Mitsunori Hayashi; Masafumi Mukamoto; Nobuyuki Sasakawa; Shunji Kozaki
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

2.  Novel ganglioside-mediated entry of botulinum neurotoxin serotype D into neurons.

Authors:  Abby R Kroken; Andrew P-A Karalewitz; Zhuji Fu; Jung-Ja P Kim; Joseph T Barbieri
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

3.  Subunit vaccine efficacy against Botulinum neurotoxin subtypes.

Authors:  James S Henkel; William H Tepp; Amanda Przedpelski; Robert B Fritz; Eric A Johnson; Joseph T Barbieri
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

4.  Dynamin inhibition blocks botulinum neurotoxin type A endocytosis in neurons and delays botulism.

Authors:  Callista B Harper; Sally Martin; Tam H Nguyen; Shari J Daniels; Nickolas A Lavidis; Michel R Popoff; Gordana Hadzic; Anna Mariana; Ngoc Chau; Adam McCluskey; Phillip J Robinson; Frederic A Meunier
Journal:  J Biol Chem       Date:  2011-08-05       Impact factor: 5.157

5.  Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction.

Authors:  Cesare Colasante; Ornella Rossetto; Laura Morbiato; Marco Pirazzini; Jordi Molgó; Cesare Montecucco
Journal:  Mol Neurobiol       Date:  2013-03-08       Impact factor: 5.590

6.  Interneuronal Transfer and Distal Action of Tetanus Toxin and Botulinum Neurotoxins A and D in Central Neurons.

Authors:  Ewa Bomba-Warczak; Jason D Vevea; Joel M Brittain; Annette Figueroa-Bernier; William H Tepp; Eric A Johnson; Felix L Yeh; Edwin R Chapman
Journal:  Cell Rep       Date:  2016-08-04       Impact factor: 9.423

7.  Identification of the synaptic vesicle glycoprotein 2 receptor binding site in botulinum neurotoxin A.

Authors:  Jasmin Strotmeier; Stefan Mahrhold; Nadja Krez; Constantin Janzen; Jianlong Lou; James D Marks; Thomas Binz; Andreas Rummel
Journal:  FEBS Lett       Date:  2014-02-25       Impact factor: 4.124

8.  Purification and Characterization of Recombinant Botulinum Neurotoxin Serotype FA, Also Known as Serotype H.

Authors:  Gavin Hackett; Kevin Moore; David Burgin; Fraser Hornby; Bryony Gray; Mark Elliott; Imran Mir; Matthew Beard
Journal:  Toxins (Basel)       Date:  2018-05-11       Impact factor: 4.546

9.  Structural insights into the functional role of the Hcn sub-domain of the receptor-binding domain of the botulinum neurotoxin mosaic serotype C/D.

Authors:  Yanfeng Zhang; Anna S Gardberg; Thomas E Edwards; Banumathi Sankaran; Howard Robinson; Susan M Varnum; Garry W Buchko
Journal:  Biochimie       Date:  2013-03-21       Impact factor: 4.079

10.  SV2 mediates entry of tetanus neurotoxin into central neurons.

Authors:  Felix L Yeh; Min Dong; Jun Yao; William H Tepp; Guangyun Lin; Eric A Johnson; Edwin R Chapman
Journal:  PLoS Pathog       Date:  2010-11-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.